Source link : https://newshealth.biz/health-news/alternative-endpoints-in-phase-iii-trials-dont-always-mean-boosts-to-os-qol/
(MedPage Today) — CHICAGO — Late-phase trials that showed superiority for an experimental intervention on a surrogate endpoint did not necessarily lead to improvements in overall survival (OS) or quality of life (QOL), according to a meta-epidemiologic… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115842 Author : Publish date : 2025-06-01 21:43:00 Copyright for syndicated content belongs to the […]
The post Alternative Endpoints in Phase III Trials Don’t Always Mean Boosts to OS, QOL first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-01 21:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8